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THE PROTEINS IN PEMPHIGTJS VULGARIS*
III. Ths EFFECT OF INFUSIONS OF HUMAN SRuM ALBUMIN ON THE PROTEINS
IN THE BLOOD SERUM OF PATIENTS WITH PEMPHIGUS VULGARIS
WALTER F. LEVER, M.D. AND JAMES G. MAcLEAN, M.D.
In a previous paper of this series (1) it was shown that in the advanced stage
of pemphigus vulgaris acutus the amount of serum albumin, as measured by
electrophoresis, is markedly reduced, often to values as low as one-fourth of the
normal value. The reason for the marked hypoalbuminemia was seen in the
considerable loss of protein through the denuded skin surfaces. While all pro-
tein fractions are lost (2), the globulins are regenerated in adequate amounts;
on the other hand, the albumin apparently cannot be regenerated at the rate
at which it is lost.
Albumin is an important fraction of the serum protein concerned especially
with the regulation of the osmotic equilibrium between the blood and tissue
fluids (1). Therefore, the possibility was considered that the marked reduction
of the serum albumin was at least a contributing factor in the death of some of
the patients with pemphigus vulgaris acutus.
On the basis of these findings and considerations 5 patients who were in the
advanced stage of pemphigus vulgaris acutus and had marked hypoalbuminemia
were given infusions of serum albumin. The effect of this treatment is reported in
this communication.
REVIEW OF LITER!tTURE
Janeway, Gibson, Woodruff, Heyl, Bailey and Newhouser (3) first demon-
strated in 1944 that the serum albumin level of patients with hypoalbuminemia
due to either inanition, cirrhosis of the liver or nephrosis can be raised by the
intravenous administration of large amounts of albumin. However, the rise of
the albumin in cirrhosis of the liver and in nephrosis was only temporary. The
authors concluded, therefore, that the use of albumin in such patients was
chiefly indicated to tide them over an emergency. Thorn and his coworkers (4, 5)
confirmed these findings. They found that in severe nephrosis the albumin level
fell to pretreatment values within 10 days following the most extensive albumin
treatment (1500 grams over 30 days), because most of the infused albumin was
lost by the way of urinary excretion. In patients with cirrhosis the time required
for the serum albumin to fall to the initial level was more than three times as
long as in nephrosis.
MATERIAL AND METHODS
The low-salt human serum albumin used in this study was prepared from
plasma according to the method developed by Cohn and his coworkers (6) and
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was supplied in vials containing 25 grams of albumin in 100 ml. of solution.'
Thus, each vial contained the amount of albumin present in approximately 1200
ml. of whole blood.
The concentration of total protein in the blood serum was determined by the
micro-Kjeldahl method using a nitrogen factor of 6.25. For the chemical deter-
mination of the serum albumin and globulin the Howe method (7) was used
in which the globulins are salted out by sodium sulfate.
Electrophoretic analyses were carried out in the Tiseius apparatus on either
serum or plasma as described in a previous paper of this series (1). Sodium diethyl
barbiturate at pH 8.6 and ionic strength of 0.1 was used as buffer.
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Fj. 1. First patient, descending patterns. The left upper pattern was obtained on Jan-
ary 24, 1949, before treatment; the right upper pattern on February 3, after 5 albumin
infusions; the left lower pattern on February 7, after 4 additional albumin infusions and
2 blood transfusions; and the right lower pattern on February 28, three weeks after the last
albumin infusion.
Plasma volume determinations were made by the method of Gibson and Evans
(8) using Gibson and Evelyn's adaptation of the method to the photoelectric
colorimeter (9).
REPORT OF CASES
Case 1. A Jewish woman, aged 41, with severe pemphigus vulgaris acutus of four months'
duration received from January 29 to February 6, 1949 nine daily infusions of 25 grams of
albumin. The serum protein rose from 3.60 grams to 4.89 grams per 100 ml., and the albumin,
as measured by electrophoresis, from .86 grams to 2.23 grams per 100 ml. (Fig. 1 and Ta-
ble 1). Three weeks after the last infusion, on February 28, 1949 the serum protein still
measured 4.88 grams per 100 ml., but the amount of albumin had decreased to 1.56 grams
1 This material was collected by the Red Cross from voluntary donors and was prepared
at the Division of Biologic Laboratories of the Massachusetts Department of Health.
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per 100 ml. Although the albumin infusions temporarily increased the patient's strength,
the patient died of pemphigus on March 4, 1949.
TABLE I
Electrophoretic data on the blood serum of patients treated with human serum albumin
ABSOL. IZCTROPEOE. CONC.
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Fro. 2. Second patient, descending patterns. The left pattern was obtained on February
21, 1949, before treatment; and the right pattern on February 25, after 4 albumin infusions
Case . AJewish male, aged 56, had severe pemphigus vulgaris acutus of 5 months' dura-
tion. From January 27 to February 21, 1949, he received 40 to 60 grams of protein hydrol-
ysate daily by mouth. In spite of this treatment the serum protein decreased from 6.70
grams to 5.46 grams per 100 ml. and the albumin from 3.12 to 1.23 grams per 100 ml. On
February 21 daily infusions of 25 grams of albumin were started. After 4 infusions the serum
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* In patient 4 the first three electrophoretic analyses were carried out on plasma rather
than on serum. The fibrinogen migrates with the $-2 peak.
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protein had risen to 5.82 grams and the albumin to 1.92 grams per 100 nil. (Fig. 2 and Table
1). Following the 7th infusion the patient suddenly developed pulmonary edema and died.
Case . A Jewish woman, aged 53, had severe pemphigus vulgaris acutus of 4 months'
duration. She received 5 infusions of 25 grams of albumin and 3 transfusions of 450 ml. of
bloodon alternate days between March 8 and March 17, 1949. In addition, 42 grams of aureo-
mycin was given from March 8 to 21. The serum protein rose from 5.05 grams to 6.10 grams
TABLE II
Electrophoretic and Howe values of serum protein, hernatocrit, blood volume and total circu-lating albumin of patients treated with human serum albumin
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* This value is based on the electrophoretic albumin value.
per 100 ml., the albumin from 1.48 to 2.58 grams per 100 ml. (Table 1), and the total circu-
lating albumin from 48.1 to 61.9 grams (Table 2). The hematocrit rose from 28.5 to 36 per
cent.
Four weeks after the last infusion the level of the serum protein had not fallen. The
serum albumin, however, had decreased to 1.46 grams per 100 ml. and the total circulating
albumin to 57.2 grams. The hematocrit had fallen to 20.5 per cent. Thereupon, 5 infusions of
25 grams of albumin and 5 transfusions of 450 ml. of blood were administered on alternate
days between April 15 and 24, 1949. In addition, aureomycin was reinstituted onApril 14.
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Fourgrams a day was given for one week, and 2 grams a day thereafter. The serum protein
increased to 7.20 grams per 100 ml., the serum albumin to 2.98 grams per 100 ml. (Fig. 3 and
Table 1), and the total circulating albumin to 83.4 grams (Table 2). The hematocrit rose to
44 per cent. The patient's condition improved considerably. Twelve days after the last
albumin infusion, on May 6, 1949, the amount of albumin had further increased, to 350
grams per 100 ml.
The patient remained in good condition, with only a few oral lesions, from May until
early October 1949. Then the disease became active again. Aureomycin, 3 to 4 grams a day,
was resumed, but the disease progressed rapidly. The patient was readmitted to the hos-
pital on November 21, 1949. The serum protein measured 5.22 grams and the serum albumin
1.39 grams per 100 ml. Albumin infusions were resumed, but the patient died of pemphigus
on December 7, 1949, after having received only 4 infusions of albumin.
/ a2a1A y $1a2aA
Fio. 3. Third patient, descending patterns. The left pattern was obtained on April 4,
1949, before the second series of treatments; and the right pattern on April 29, after 5 al-
bumin infusions and 5 blood transfusions.
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FIG. 4. Fourth patient, ascending patterns. The left pattern was obtained on October 27,
1949, before treatment; the pattern in the center on November 4, after 4 albumin infusions
and 4 blood transfusions; and the right pattern on November 14, after an additional 5 albu-
min infusions and 4 blood transfusions.
Case 4. A Jewish male, aged 54, with severe pemphigus vulgaris acutus of 7 months' dura-
tion received 9 infusions of 25 grams of albumin and 8 transfusions of 450 ml. of blood on
alternate days from October 27 to November 12, 1949. Simultaneously, the patient received
4 grams of aureomycin per day. The serum protein rose from 5.41 to 6.55 grams per 100 ml.,
the albumin from .75 grams to 2.73 grams per 100 ml., and the total circulating albumin
from 27.3 to 96.6 grams (Fig. 4 and Tables 1 and 2). The hematocrit rose from 30 to 45.9
per cent. The patient's general condition improved and his cutaneous lesions healed to some
extent. The patient returned to his home on November 15, 1949. He continued taking 4
grams of aureomycin a day. While at home, his general condition deteriorated gradually.
Three months after the last albumin infusion, on February 15, 1950, the total protein
measured 5.12 grams and the serum albumin 1.15 grams per 100 nil. Death from pemphigus
occurred on March 2, 1950.
Case 5. A French-Canadian woman, aged 59, had oral lesions since September 1949 and
cutaneous lesions since early December 1949. The lesions spread with great rapidity. The
220 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
patient was admitted to the hospital with a diagnosis of pemphigus vulgaris acutus. From
December 15 to December 29, 1949, eight infusions of 25 grams of albumin were given on
alternate days. In spite of this, the serum albumin concentration fell from 1.97 grams to
1.67 grams per 100 ml. (Table 1). Thereafter, infusions of albumin were given daily for six
days. On January 6, 1950 the amount of albumin had increased to 2.27 grams per 100 ml.
In addition to the albumin, aureomycin, 3 to 4 grams a day, was given beginning December
14, 1949. The cutaneous lesions, however, continued to extend, the patient's general con-
dition deteriorated rapidly and death occurred on January 5, 1950.
DISCUSSION OF EFFECTS OF TREATMENT
Chemical effect
In 3 Of the 5 patients (Patients 1, 3 and 4) the marked reduction of the serum
albumin was effectively counteracted by adequate infusions of albumin. This is
in contrast to the oral administration of protein hydrolysates, a procedure which,
in our experience, has proved entirely ineffective to correct the marked hypo-
albuminemia of patients with pemphigus vulgaris acutus.
In 1 patient (Patient 2) a slight rise of the albumin level had occurred after
4 infusions of albumin. No further determinations could, however, be carried out
because, following the seventh infusion, the patient suddenly died from pul-
monary edema attributable to the albumin infusions (see below, Dangers of
Treatment).
In 1 patient (Patient 5) the disease was fulminant in its course. Eight in-
fusions of albumin given on alternate days did not prevent a further falling of the
albumin level. Only when daily infusions were administered, did the albumin
level rise.
A study of the long range effect of the albumin infusions is of interest. Since
the hypoalbuminemia is caused mainly by the considerable loss of protein
through the large denuded skin surfaces it was expected that the correction of the
hypoalbuminemia would be temporary only, unless the disease improved. Pa-
tients 1, 3 and 4 were followed over longer periods of time. In patient 1 the
albumin, calculated per 100 ml. of serum, had fallen, 3 weeks after the last in-
fusion, to a level of 1.56 gram per 100 ml., half-way between the pre-treatment
level of 0.86 gram and the post-treatment level of 2.33 grams per 100 ml.; but
the serum protein had remained at the level existing after the last infusion. In
patient 3, the amount of albumin per 100 ml. had fallen, four weeks after the
first series of infusions, to the previous low level of 1.46 gram per 100 ml., but
the serum circulating albumin had decreased only slightly from 61.9 grams to
57.2 grams, and the serum protein had remained at the level existing after the
last infusion (Table 2). In patient 4, the serum protein had fallen, three months
after the last infusion, to the previous low level; but the albumin still measured
1.15 grams per 100 ml., as compared with 0.75 grams per 100 ml. before the
series of infusions. Thus the effect of adequate albumin infusion therapy in pa-
tients with pemphigus vulgaris seems to extend over many weeks. Nevertheless,
unless the disease itself improves, the amount of albumin will gradually decrease,
making it advisable to repeat the treatment after some weeks, as was done in
patient 3.
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Clinical effect
The infusion of albumin appeared to have no direct effect on the disease itself.
As seen in patient 5, death from pemphigus can occur even when the hypoalbu-
minemia is fairly well controlled. However, in several patients (Patients 1, 3
and 4), the infusions brought about an increase in strength and improvement
of the general condition.
In conclusion, the value of the albumin infusions in the treatment of patients
with pemphigus vulgaris acutus lies in the correction of a complication, hypo-
albuminemia, which in itself can have serious consequences (1). Albumin in-
fusions in patients with hypoalbuminemia due to pemphigus serve a similar
purpose as blood transfusions do in patients with anemia due to excessive loss of
blood. In both instances, the purpose of the treatment is replacement of the loss
of a biologically important substance.
DANGERS OF TREATMENT AND PRECAUTIONS NECESSARY
Infusions of large amounts of albumin are associated with one danger for
which precautions must be taken. Albumin, due to its high osmotic activity,
draws considerable amounts of interstitial fluid into the blood stream. According
to Scatchard and coworkers (10), each gram of albumin should increase the circu-
lating plasma volume by about 18 ml. of fluid. When rapidly infused, this sudden
increase in plasma volume may lead to pulmonary edema and death (3).
One previous death due to pulmonary edema has been reported (3) in a pa-
tient who had received a total of 650 grams of albumin in six days. Cognizant
of this fact, the 100 ml. of albumin solution was diluted to 250 ml. with normal
saline and administered slowly over a period of one hour. In spite of this, death
from pulmonary edema occurred in our second patient after the seventh infusion.
This patient had had an attack of coronary occlusion five years previously but
had shown no cardiac impairment at the time the treatment with albumin in-
fusions was started. No symptoms of respiratory embarrassment occurred after
the first six infusions, but began suddenly two hours after the seventh infusion.
Following this accident the following precautions were set up: 1. The size of
the heart is determined radiographically and its function checked by electro-
cardiogram. 2. Infusions of 25 grams of albumin are given preferably not oftener
than every other day. (Blood transfusions may be given on the alternate days.)
For the infusion the 100 ml. solution of albumin is diluted with 350 ml. of 5 per
cent glucose solution, making the mixture osmotically equivalent to citrated
plasma. The intravenous infusion is given at a rate of about 20 drops a minute,
thus requiring approximately four hours. 3. The blood pressure, the rate of
respiration and the pulse rate are checked every two hours during and after the
infusion for at least six times. At the same time, both lungs are examined by
stethoscope for the presence of rales. No accident has occurred since these pre-
cautions have been put into effect.
SUMMARY
Five patients with severe pemphigus vulgaris acutus and marked hypoalbu-
minemia received infusions of human serum albumin.
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Administration of adequate amounts of albumin resulted in an appreciable
rise of the serum albumin.
The infusions of albumin had no effect on the disease as such but improved
the general condition of the patients.
The administration of albumin by infusion is not without danger unless ade-
quate precautions are adopted.
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